Sep 12, 2018 8:00am EDT Veru has Successful Pre-IND Meeting with FDA for VERU-111 Next Generation Novel Oral Anti-Tubulin Therapy for Metastatic Prostate Cancer
Aug 30, 2018 8:00am EDT Veru to Ring NASDAQ Closing Bell on August 31 to Kick Off National Prostate Cancer Awareness Month
Aug 29, 2018 8:00am EDT Veru Announces Additional Information Regarding its South Africa Female Condom Tender Award
Aug 07, 2018 4:08pm EDT Veru to Report Fiscal 2018 Third-Quarter Financial Results, Host Conference Call on August 14th
Jun 12, 2018 8:30am EDT Veru to Start Phase 2 Trial to Evaluate Cis-Clomiphene Citrate to Treat Hot Flashes Caused by Advanced Prostate Cancer Therapy
